Results for &quot;&quot;Imidazolidines&quot;&quot;[mesh_terms]

Molecular recognition of peptides and proteins by cucurbit[]urils: systems and applications.

Nia Clements, Lilyanna Armstrong, Sarah L Chang, Zoheb Hirani, Lauren B Kimberly, Keturah Odoi-Adams, Paolo Suating, Hailey F Taylor, Sara A Trauth, Adam R Urbach

Chemical Society reviews 2024;53(23):11519-11556

Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond.

H Pürerfellner

Current medicinal chemistry. Cardiovascular and hematological agents 2005;2(1):79-91

Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.

Stefan H Hohnloser, Hussein R Al-Khalidi, Craig M Pratt, Jose M Brum, Daljit S Tatla, Patrick Tchou, Paul Dorian

European heart journal 2007;27(24):3027-32

Long-term treatment with imidapril but not with nifedipine enhances plasma NOx concentration in patients with essential hypertension.

Osamu Suda, Masato Tsutsui, Tsuyoshi Morishita, Masataka Horiuchi, Sei Nakata, Ryouji Kouzuma, Masahiro Okazaki, Akiko Sumiyama-Fujinishi, Tsunetaka Mizuki, Nobuyuki Yanagihara, Hiromi Tasaki, Yasuhide Nakashima

Journal of pharmacological sciences 2006;101(2):159-65

Clinical differences between the newer antiarrhythmic agents.

A J Camm

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2001;1 Suppl C():C16-22

A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension.

R van der Does, R Euler

The Journal of international medical research 2001;29(3):154-62

Treatment of diabetic neuropathy and neuropathic pain: how far have we come?

Dan Ziegler

Diabetes care 2008;31 Suppl 2():S255-61

Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors.

Huimin Yu, Shuguang Lin, Yuqing Zhang, Guozhang Liu

Journal of hypertension 2008;26(2):251-6

Effect of Solution Ionic Strength on the pK of the Nitroxide pH EPR Probe 2,2,3,4,5,5-Hexamethylimidazolidin-1-oxyl.

Kaleigh Margita, Maxim A Voinov, Alex I Smirnov

Cell biochemistry and biophysics 2017;75(2):185-193

Influence of ketoconazole on azimilide pharmacokinetics in healthy subjects.

Mohamed El Mouelhi, Dan J Worley, Barbara Kuzmak, Anthony J Destefano, Gary A Thompson

British journal of clinical pharmacology 2005;58(6):641-7

Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues.

Deborah L Wolbrette

The American journal of cardiology 2003;91(6A):39D-44D

Multiple imputation to estimate the association between eyes in disease progression with interval-censored data.

Bernard Rosner, Robert J Glynn

Statistics in medicine 2005;23(21):3307-18

Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.

S J Connolly, D J Schnell, R L Page, W E Wilkinson, S R Marcello, E L Pritchett

The American journal of cardiology 2001;88(9):974-9

The effect of isoproterenol on the class III effect of azimilide in humans.

David Newman, Paul Dorian, Preston Dunnmon, Laura Elstun

Journal of cardiovascular pharmacology and therapeutics 2003;7(4):211-7